Newsroom | 97146 results

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following conferences: Guggenheim Emerging Outlook: Biotech Summit 2026 Format: Management will participate in a fireside chat and investor meetings Date: Thursday, February 12 at 9:00 a.m. ET TD Cowen 46th Annual Health Care Conference F...

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectoryY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today the appointment of Kevin Pojasek, Ph.D., to its Board of Directors. Dr. Pojasek brings more than two decades of expertise founding, scaling, and leading innovative biopharma companies, with deep expertise across corporate strategy, business development, and research and development. Dr. Pojasek is currently president and chief executive officer of...

BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data and physician experiences will highlight how vMap can help improve procedural efficiency, enhance arrhythmia termination, and help enable post-ablation non-inducibility. At this year’s meeting, a featured study titled “High Procedural Efficiency and Arrhythmia Non-Inducibil...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended December 31, 2025. "IQVIA closed 2025 with strong performance across all segments," said Ari Bousbib, chairman and CEO of IQVIA. "We delivered near double digit revenue and EPS growth, and the strongest...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025...

SHEFFIELD, England--(BUSINESS WIRE)--SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters. Developed using SynGenSys’ proprietary informatics and computational design platform, the Liver.SET library comprises a range of compact, patentable synthetic promoters for liver-targeted...

SAN SEBASTIÁN, España--(BUSINESS WIRE)--Quantum Motion ha anunciado hoy la inauguración de su sucursal en España, estableciendo así una base permanente para el desarrollo, la integración y el despliegue de sistemas cuánticos en la Unión Europea. La nueva sede, ubicada en la recién inaugurada nanoGUNE Quantum Tower, respalda la ampliación de los sistemas de computación cuántica con silicio de Quantum Motion y consolida la colaboración entre los ecosistemas semiconductores, académicos e industria...

SAN SEBASTIAN, Spain--(BUSINESS WIRE)--Quantum Motion today announced the opening of its offices in Spain, establishing a permanent base for quantum system development, integration and deployment in the European Union. The new site, which is located in the newly inaugurated nanoGUNE Quantum Tower, supports Quantum Motion’s scale-up of silicon-based quantum computing systems and strengthens the collaboration across Europe’s semiconductor, academic and industrial ecosystems. The nanoGUNE Quantum...

MINATO-KU, TOKIO, Japan & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (Zentrale: Minato-ku, Tokio; President & CEO: Goki Ishikawa; „Fujirebio“), eine konsolidierte Tochtergesellschaft der H.U. Group Holdings, Inc. (Zentrale: Minato-ku, Tokio; Chairman, President und Group CEO: Shigekazu Takeuchi) und die Sysmex Corporation (Zentrale: Kobe, Japan; President: Kaoru Asano, „Sysmex“) haben eine Vertriebskooperation für Demenztests vereinbart. Diese Vereinbarung ist das Ergebnis fortg...